Literature DB >> 1360870

Allelic loss from chromosome 11 in parathyroid tumors.

E Friedman1, L De Marco, P V Gejman, J A Norton, A E Bale, G D Aurbach, A M Spiegel, S J Marx.   

Abstract

Parathyroid tumors may occur in a sporadic fashion or, more rarely, as part of a familial syndrome (such as familial multiple endocrine neoplasia type I). The MENI gene has been mapped by linkage analysis to chromosome 11 at band q11-q13, and presumably acts as a tumor suppressor gene. In the present study, which is an extension of our previous studies, we examined 41 parathyroid tumors from patients with familial multiple endocrine neoplasia type I and 61 sporadic parathyroid tumors with markers on chromosome 11, to assess the extent of allelic loss in those tumors. Twenty-four of the MENI-associated tumors (58%) and 16 of the sporadic parathyroid tumors (26%) displayed allelic loss from chromosome 11. The region of overlap of the allelic losses in the MENI-associated tumors enables us to place the MENI gene between PGA centromerically and INT2 telomerically, a region spanning about 7.5 cM. Taken together with locus ordering by linkage analysis, this clearly localizes the MENI gene telomeric to the PGA locus. Our inability to detect allelic loss on chromosome 11 in some parathyroid tumors suggests the existence of other genes involved in the development and/or progression of this subgroup of presumably monoclonal tumors; or that localized events involving the 11q tumor suppressor gene have occurred in some parathyroid tumors whose detection is beyond the sensitivity of our analysis; or that at least some of the specimens analyzed were in fact primarily hyperplastic parathyroid tissue.

Entities:  

Mesh:

Year:  1992        PMID: 1360870

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

Authors:  S C Guru; S K Agarwal; P Manickam; S E Olufemi; J S Crabtree; J M Weisemann; M B Kester; Y S Kim; Y Wang; M R Emmert-Buck; L A Liotta; A M Spiegel; M S Boguski; B A Roe; F S Collins; S J Marx; L Burns; S C Chandrasekharappa
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

2.  Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.

Authors:  S Grimmond; G Weber; C Larsson; M Walters; B Teh; J Shepherd; M Nordenskjold; N Hayward
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

Review 3.  [Multiple endocrine neoplasia Type I. Diagnosis and therapy in a case with classical family history].

Authors:  R Lamberts; M Gregor
Journal:  Med Klin (Munich)       Date:  1999-08-15

4.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus.

Authors:  H P Tala; C A Carvajal; A A González; J L Garrido; J Tobar; A Solar; C Campino; E Arteaga; C E Fardella
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

6.  Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Authors:  D Scarpelli; L D'Aloiso; F Arturi; A Scillitani; I Presta; M Bisceglia; C Cristofaro; D Russo; S Filetti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

7.  MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; E Vignali; S Borsari; A Picone; L Cianferotti; E Ambrogini; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

8.  Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.

Authors:  M Sato; S Matsubara; A Miyauchi; H Ohye; H Imachi; K Murao; J Takahara
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

9.  Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma.

Authors:  Lin Zhao; Li-hao Sun; Dong-mei Liu; Xiao-yan He; Bei Tao; Guang Ning; Jian-min Liu; Hong-yan Zhao
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

10.  p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas.

Authors:  Begona Arribas; Eva Cristobal; Jose A. Alcazar; Juan Tardio; Juan C. Matinez-Montero; Jose R. Polo; Rafael Carrion; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.